RE-BVS – Piemonte Repository

Sfoglia per AUTORE
NUMICO G
Collezione ASL Cuneo 2

Items : 5

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.

2024
ASL Città di Torino
AO Cuneo
ASL Asti
ASL Cuneo 2
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Maio MD; Buttigliero C; Vignani F; Dionisio R; Icardi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Airoldi M; Rossi M; Vellani G; Ortega C; Ruatta F; Tucci M; Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; et alii...

Liver toxicities during cyclin-dependent kinase inhibitors (CDKi) in patients affected by hormone receptor-positive breast cancer (BC) in Annals of Oncology

2023
ASL Cuneo 2

Paratore C; Audisio M; Bombaci S; Bungaro M; Dionisio R; Ferrari G; Gaudino E; Grassi L; Hotca A; Loddo C; Manuguerra G; Manzin E; Novello S; Numico G; Persano I; Sculli C; Sperone P; Valsecchi AA; Zucchini G; Vellani G;

Safety and efficacy of abiraterone in elderly patients with metastatic castration-resistant prostate cancer: Multicentric real-life experience in Anticancer Research

2018
ASL Cuneo 2

Sirotova Z; Courthod G; Tartarone A; Caffo O; Maines F; Prati V; Bertuccelli M; Mosca A; Fornarini G; Guglielmini P; Morelli F; Palesandro E; Ortega C; Miraglia S; Perrone V; Numico G; Allegrini G; Aieta M; Schena M;

Safety and efficacy of abiraterone acetate (AA) in patients aged 75 or more with metastatic castration-resistant prostate cancer (mCRPC) in both pre-chemotherapy or post-chemotherapy settings: Real-life experience from thirteen Italian centers in Journal of Clinical Oncology

2018
ASL Cuneo 2

Sirotova Z; Courthod G; Tartarone A; Caffo O; Maines F; Bertuccelli M; Morelli F; Numico G; Guglielmini P; Fornarini G; Prati V; Palesandro E; Ortega C; Mosca A; Miraglia S; Perrone V; Fea E; Allegrini G; Mozzicafreddo A; Schena M;

Osteonecrosis of jaw (ONJ) after antiresorptive treatment (bisphosphonates, denosumab) of cancer-treatment induced bone loss (CTIBL): A negligible risk? in Annals of Oncology

2017
AOU Città della Salute di Torino
AOU Alessandria
ASL Cuneo 2

Gambino A; Cabras M; Fusco V; Bertetto O; De Martino I; Alessio M; Numico G; Cagnazzo C; Arizio F; Piccinni Leopardi M; Di Costanzo A; Crotto L; Matocci R; Lucarelli A; Grassi E; Saracino V; Fugazza C; Cinefra M; Marchetti F; Taverniti C; Stabile S; Monti M; Marchesi E;